Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan‐gel Against Transmission of Cervical Human papillomavirus (CATCH) trial
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29604 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Cassandra Laurie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Papillomavirus Infections, Sexually Transmitted Diseases, Uterine Cervical Neoplasms, Alphapapillomavirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Previous research has shown that women's use of a carrageenan gel reduces the risk of acquiring genital human papillomavirus (HPV) infections but does not help to clear existing ones. Although gel use may not result in complete clearance, it may decrease the viral load of HPV infections. We tested this hypothesis in the Carrageenan‐gel Against Transmission of Cervical Human papillomavirus (CATCH) randomized controlled trial. Participants of the CATCH study were selected for viral load testing if they had completed the first four study visits and tested positive for HPV42 or HPV51 in at least one of these visits. HPV42 and HPV51 were chosen as they were among the most abundant low‐ and high‐risk types, respectively, in the study sample. We measured viral load with a type‐specific real‐time polymerase chain reaction. Results were displayed using summary statistics. Of 461 enrolled participants, 39 were included in the HPV42 analysis set and 56 in the HPV51 analysis set. The median time between visits 1 and 4 was 3.7 months. The viral load (copies/cell) of HPV42 ranged from
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Epidemiology, McGill University, Montreal, Canada.
- Epidemiology Department, Merck & Co. Inc., Rahway, New Jersey, USA.
- Department of Family Medicine, McGill University, Montreal, Canada.
- Laboratoire de Virologie Moléculaire, Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), et Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Canada.
- Department of Family and Community Medicine, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada.
ORCID-Profile: Cassandra Laurie, Mariam El-Zein, François Coutlée, Eduardo L Franco
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Laurie, C., El-Zein, M., Tota, J. E., Tellier, P. P., Coutlée, F., Burchell, A. N., & Franco, E. L. (2024). Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan‐gel Against Transmission of Cervical Human papillomavirus (CATCH) trial. Journal of Medical Virology. https://doi.org/10.1002/jmv.29604
Vancouver
Laurie C, El-Zein M, Tota JE, Tellier PP, Coutlée F, Burchell AN, et al. Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan‐gel Against Transmission of Cervical Human papillomavirus (CATCH) trial. Journal of Medical Virology. 2024. doi:10.1002/jmv.29604
BibTeX
@article{Laurie2024,
author = {Laurie, Cassandra and El-Zein, Mariam and Tota, Joseph E and Tellier, Pierre-Paul and Coutlée, François and Burchell, Ann N and Franco, Eduardo L},
title = {Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan‐gel Against Transmission of Cervical Human papillomavirus (CATCH) trial},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29604}
}
EUVIMED